Acrivon Therapeutics Inc at TD Cowen Oncology Innovation Summit (Virtual) Transcript
Hi. Welcome to the TD Cowan Oncology Innovation Summit that we host annually right ahead of the big ASCO meeting. Of course, we'll also talk about things that are beyond just the scope of ASCO.
We're really happy to kick things off this morning with the team here with Peter, the CEO of Acrovant Therapeutics, where we're going to talk about their program, primarily their program in endometrial cancer.
As well as some of the deeper pipeline assets. Maybe to start off, I will hand it to Peter to kind of provide a kind of high-level overview to kind of level set investors. I think Peter has got a few slides he's going to run through as part of that, and then we will jump into questions.
Which I've come up with before, but also this can be interactive. There is the portal for the investors on the line to log their own questions into the system. You can either use that portal or you can e-mail me directly at [email protected], and I will add them to the list. With that, Peter, if you want to kind of do that high-level overview.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
